🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 10 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/09/2019 78,62 78,62 75,24 77,95 -2,13% 4,30% 18.087.432
09/09/2019 82,54 82,56 79,12 79,65 -3,58% 4,16% 12.040.786
06/09/2019 82,58 82,95 82,36 82,61 +0,55% 0,72% 7.047.695
05/09/2019 82,67 82,69 81,58 82,16 +0,06% 1,34% 7.524.954
04/09/2019 83,15 83,18 81,51 82,11 -0,69% 2,01% 7.868.070
03/09/2019 82,29 83,02 82,10 82,68 +0,21% 1,12% 6.695.882
30/08/2019 83,13 83,23 82,22 82,51 -0,29% 1,21% 6.795.127
29/08/2019 83,08 83,35 82,23 82,75 +0,28% 1,34% 6.321.012
28/08/2019 81,36 82,61 81,15 82,52 +1,12% 1,79% 6.159.934
27/08/2019 82,46 82,94 81,54 81,60 -0,42% 1,70% 6.527.049
26/08/2019 81,47 81,97 81,18 81,95 +1,11% 0,96% 6.041.825
23/08/2019 82,27 82,96 80,61 81,05 -2,05% 2,85% 10.608.694
22/08/2019 82,78 83,21 82,30 82,75 -0,22% 1,10% 6.588.776
21/08/2019 82,34 83,25 82,19 82,93 +1,47% 1,30% 6.486.072
20/08/2019 82,07 82,76 81,66 81,73 -0,63% 1,34% 6.176.598
19/08/2019 81,67 82,57 81,54 82,24 +1,33% 1,26% 7.655.221
16/08/2019 80,58 81,45 80,30 81,16 +1,92% 1,43% 9.156.271
15/08/2019 79,69 80,01 79,09 79,64 +0,07% 1,15% 9.543.612
14/08/2019 81,46 81,91 79,53 79,58 -3,11% 2,92% 11.411.148
13/08/2019 81,55 82,81 81,55 82,14 +1,25% 1,56% 8.413.658
12/08/2019 81,33 81,99 80,65 81,13 -0,58% 1,65% 8.761.909
09/08/2019 81,20 82,17 80,83 81,60 +0,93% 1,65% 8.968.260
08/08/2019 80,87 81,15 80,46 80,85 +0,57% 0,86% 8.699.762
07/08/2019 80,35 80,81 79,01 80,39 -0,12% 2,24% 11.509.660
06/08/2019 79,31 80,61 79,29 80,49 +1,48% 1,66% 11.025.274
05/08/2019 80,01 80,48 78,40 79,31 -1,60% 2,60% 11.885.578
02/08/2019 80,04 80,89 79,72 80,60 +0,93% 1,45% 10.913.767
01/08/2019 79,26 80,63 78,86 79,86 +0,84% 2,24% 10.550.006
31/07/2019 79,10 80,77 79,05 79,19 -0,34% 2,18% 12.443.428
30/07/2019 80,14 81,27 79,03 79,46 +0,95% 2,80% 14.286.965